Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Azienda Ulss 2 Marca Trevigiana

Clinical trials sponsored by Azienda Ulss 2 Marca Trevigiana, explained in plain language.

Completed 2
Sort by
  • 88% of patients with asthma and nasal polyps achieve dual remission on dupilumab

    Disease control Completed

    This study looked at 28 adults with both severe asthma and chronic sinusitis with nasal polyps who were treated with dupilumab for 24 months. The goal was to see if the drug could help control both conditions at the same time, called 'dual remission.' After 24 months, 88% of pati…

    Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Disease control

    Last updated Jun 27, 2026 12:30 UTC

  • Yoga and body awareness show promise for eating disorder recovery

    Symptom relief Completed

    This pilot study tested whether adding weekly Hatha yoga or a body-focused therapy (FSB) to standard treatment can improve body image and eating behaviors in young women aged 16-25 with anorexia or bulimia. 54 participants were split into three groups: standard care alone, standa…

    Phase: NA • Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Symptom relief

    Last updated Jun 27, 2026 12:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space